Human papillomavirus infection is principally found with cervical intra-epithelial neoplasia-III in Toluca, State of Mexico  by Mendieta-Zerón, Hugo & de León-Escobedo, Raúl
JH
f
i
H
a
J
b
P
R
1
dournal of Infection and Public Health (2009) 2, 41—46
uman papillomavirus infection is principally
ound with cervical intra-epithelial neoplasia-III
n Toluca, State of Mexico
ugo Mendieta-Zeróna,∗, Raúl de León-Escobedob,1
Faculty of Medicine, Autonomous University of the State of Mexico (UAEMex), Paseo Tollocan ESQ,
esús Carranza, Col. La Moderna, CP. 50180, Toluca, State of Mexico, Mexico
Department of Pathology, General Regional Hospital 220, Instituto Mexicano del Seguro Social (IMSS),
aseo Tollocan No. 660, Col. Vértice, CP. 50150, Toluca, State of Mexico, Mexico
eceived 17 September 2008; received in revised form 28 December 2008; accepted 12 January 2009
KEYWORDS
Cervical intra-epithelial
neoplasia;
Cervical-uterine cancer;
Detection;
Human papillomavirus
Summary
Introduction: To describe the prevalence of human papillomavirus infection (HPV)
in cases of cervical intra-epithelial neoplasia (CIN), micro-invasive carcinoma and
invasive carcinoma in Toluca, State of Mexico.
Materials and methods: Cross-sectional study analysing slides with the diagnosis
of CIN I to invasive carcinoma for one year and reporting the presence of HPV;
also identifying these cervical-uterine cancer stages noted during one semester in
the registery of histopathological studies, at the Department of Pathology, General
Regional Hospital 220, Instituto Mexicano del Seguro Social (IMSS).
Results: In one year, from a total of 5755 studies, 731 (13%) were of cervical-uterine
cancer, 112 (16%) of these were positive for some stage of cervical cancer and 46.43%
had HPV infection. In one semester, 2918 histopathological studies were done, 341
(11.68%) of these were cervix uterine biopsies, colposcopies and hysterectomies. 62
women (18.18%) diagnosed with CIN II—III, carcinoma in situ (CIS), micro-invasive
carcinoma or invasive carcinoma and ﬁnding HPV infection in 51.92% of total cases.
Conclusions: The prevalence of HPV was higher than that reported in developed
world and CIN II—III are the most common stages in Toluca, State of Mexico.
© 2009 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier
Ltd. All rights reserved.
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Introduction
The incidence of cervical-uterine cancer in the
European Union is 13.2/100,000 and the mortality
rate is 5.9/100,000 women/year [1]. In the US this
is an increasing health problem whereas in Mexico
it remains a leading cause of death for women with
an estimated incidence and mortality of 40.5 and
17.1/100,000 respectively in the year 2000. In fact,
in that year approximately 6650 women died from
this cancer, the largest number in Latin America
after Brazil.
In recent years, detection of precursor lesions of
cervical intra-epithelial neoplasia (CIN) and human
papillomavirus (HPV) infection has increased. For-
tunately, these lesions can be detected in early
stages, clarifying deﬁnitively a cytologic or col-
poscopic suspicion by histopathological study. It is
important to mention that HPV infection is capable
of causing changes similar to dysplasia, principally
CIN I, although it can simulate changes of type CIN
II or CIN III [2]. HPV infection is limited to squa-
mous epithelium (skin and mucosa) and begins in
the basal strata. Whilst the mechanisms of tumori-
genesis by HPV are not well understood, it is known
that viral replication is related to the epithelial
cell differentiation programme, possibly through
speciﬁc cellular proteins that bind to viral DNA
and regulate transcription. Some oncogenic etio-
logic factors identiﬁed are smoking, herpes virus
infection and oral contraceptive use. Based on the
frequency that a genital lesions progress to car-
cinoma, HPV are classiﬁed as low or high grade
[3].
Familial data of cervical-uterine cancer such as
low socio-economic level, multiple sexual partners,
early age of sexual intercourse, sexually transmit-
ted diseases, and infection due to HPV 18 and 35
are the factors related to high-grade squamous
intra-epithelial lesions (SIL) and cervical-uterine
cancer, even more in developing countries where
late presentation with advanced disease predom-
inates. Furthermore, among HPV-positive women,
increasing age, high viral load, high sexual activity
and a low socio-economic status are associated with
an increased risk of disease. Given this, cervical-
uterine cancer is debatebly considered a sexually
transmitted infection (STI) [4].
Previous studies have provided wide evidence
that the detection and HPV typiﬁcation can pre-
dict the future risk of developing a CIN, as well
as the risk of low-grade lesion progression [5]. It
is important to study the viral DNA because most
cases around the world establish that the infec-
tion is almost completely restricted to the high-risk
HPV types 14, 15, 16, 17 and 18. High prevalence
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f these types in certain populations could explain
egional differences in cervical cancer incidence.
Based on an evaluation of the Cervical-Uterine
ancer Early Detection Program of the Department
f Pathology, Faculty of Medicine, Autonomous Uni-
ersity of the State of Mexico (UAEMex), we would
xpect to ﬁnd a high prevalence of HPV in the dif-
erent stages of cervical cancer in Toluca, State of
exico. The aim of this study was to report the per-
entage of HPV infection related to the different
tages of CIN detected by histopathological meth-
ds and to describe the major results of biopsies
nd surgical samples with diagnosis of CIN I—III, car-
inoma in situ (CIS), micro-invasive carcinoma and
nvasive carcinoma at the Department of Pathology,
eneral Regional Hospital 220, Instituto Mexicano
el Seguro Social (IMSS), Toluca, State of Mexico.
hich is the biggest second level public hospital in
he Valley of Toluca, attending 198,428 people afﬁl-
ated to the Mexican Social Security System and the
nly pathology department processing these types
f slides for this population.
aterials and methods
his project obtained the institutional research
oard’s approval from the Faculty of Medicine of
he UAEMex.
Type of study: descriptive, retrospective.
We reviewed all the histopathological slides
repared in one year at the General Regional Hos-
ital 220, IMSS, with the diagnosis of CIN I—III,
icro-invasive carcinoma and invasive carcinoma,
dentifying those with the presence of HPV.
Secondly, we retrieved the results recorded
uring one semester in the registration book of
istopathological studies, collecting the following
ata: (1) gyneco-obstetric information and (2) type
f study [surgical tissue (S) or biopsy (B)]. All the
amples were evaluated for the diagnosis of CIN
—III, CIS, micro-invasive carcinoma and invasive
arcinoma. In addition, existence of infections,
nvasion, metaplasia, keratinisation, the differen-
iation grade and presence of other lesions was
oted.
Statistical analysis was performed using the
nStat 3 program using Fisher’s exat test for con-
ingency tables.uring this one year, the median age of patients
as 43 years old. From a total of 5755 studies,
31 (13%) were of cervical-uterine cancer, and
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Table 1 Histopathological studies done in one semester.
Cervix uterine biopsies, colposcopies
and hysterectomies
Colposcopies and
hysterectomies
Biopsies
Total 341 282 59
CIN I 0 0 0
CIN II 11 6 5
CIN III 16 9 7
CIS 21 10 11
Micro-invasive carcinoma 7 1 6
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[Invasive carcinoma 6
Adenocarcinoma 1
CIN: cervical intra-epithelial neoplasia, CIS: carcinoma in situ.
12 (16%) of these were positive for some stage
f cervical cancer (CIN I: 3; CIN II: 20; CIN III:
7; micro-invasive carcinoma: 10 and invasive
arcinoma: 12). Besides, 52 (46.43%) had HPV
nfection, CIN I: 1 (33.33%); CIN II: 8 (40%); CIN
II: 35 (52.24%); micro-invasive carcinoma: 3 (30%)
nd invasive carcinoma: 5 (41.67%). There were no
igniﬁcant statistical association between any of
he above groups and HPV.
During one semester the peak of cases was in
omen ranging between 13 and 70. The gyneco-
bstetric data was in average: gestation (G): 7.07,
aginal deliveries (VD): 2.75, abortions (A): 0.77
nd caesarean deliveries (CD): 0.19; distributed
er diagnosis were CIN II: G = 6.22, VD = 4.77, A = 1,
D = 0.44; CIN III: G = 3.92, VD = 3.33, A = 0.25,
D = 0.16; CIS: G = 5.53, VD = 5.13, A = 0.93,
D = 0.26; micro-invasive carcinoma: G = 6.66,
D = 5.66, A = 1, CD = 0; invasive carcinoma (we
ould ﬁnd information of only one patient): G = 12,
D = 12, A = 0, CD = 0.
From 2918 histopathological studies done, 59
17.30%) were biopsies and 282 (82.69%) were sur-
C
c
c
igure 1 Trends with different mortality rates incidence p
éxico 2005—2050. Consejo Nacional de Población, 2006. Avai
accessed 04.09.08].1 5
1 0
ical tissues, (the distribution per stage is showed
n Table 1).
86.5% of the samples were of good quality
nd 13.5% were suboptimal, noting endocervix in
6.53% of cases, exocervix in 96.15% and transi-
ion zone in 86.53%, ﬁnding HPV infection in 51.92%
f total cases and vascular and glandular invasion
n 17.3% each. There was squamous metaplasia in
1.92% and keratinisation in 23.07%. The grade of
ifferentiation was well deﬁned in 55.76% and poor
n 42.3%. Other lesions observed were inﬂammation
n 50%, ulceration in 46.15%, haemorrhage in 26.93%
nd necrosis in 9.61%. We found chronic cystic cer-
icitis in 23.07%, being based on the diagnosis CIN
I: 8.33%, CIN III: 25%, CIS: 58.33%, micro-invasive
arcinoma: 0% and invasive carcinoma: 8.33%.
iscussionancer of the uterine cervix is the second most
ommon cancer in women worldwide. Currently,
ervical screening is based on cytology. Many recent
rojections based on: Proyecciones de la población de
lable from: http://www.conapo.gob.mx/00cifras/5.htm
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research have highlighted the notion that low and
high-grade lesions are distinct HPV infection pro-
cesses. In contrast to low-grade SIL that tend to
be located distally from the cervical lesions, high-
grade SIL and carcinoma tend to be more proximate
[6].
Cytologic screening can detect HPV which causes
virtually all invasive cervical cancer and its precur-
sor abnormalities. As high-risk HPV infection causes
cervical cancer, it has been postulated that screen-
ing might become more efﬁcient when it is based
on cytology combined with high-risk HPV testing
[7].
Reduced Papanicolaou (Pap) smear frequency is
the primary factor attributable to development of
invasive cervical cancer. Approximately 55—60% of
cervical cancer cases arise in women who have
never been screened or who are not adherent
with screening guidelines. In this regard, coun-
tries that have implemented the Pap smear as
part of opportunistic or organised cervical cancer
screening programme that include quality assur-
ance, large population coverage, and adequate
follow-up, have experienced a reduction in the
incidence and mortality for the disease. Unfortu-
nately in Mexico, although a national screening
programme has existed since 1974, there has not
been a signiﬁcant reduction in the mortality rate
[8].
An important ﬁnding in our one-year screening
was the high percentage of cases with CIN and HPV
infection. This reinforces the assertion that HPV is
the most common STI and the most widely diag-
nosed as well. Also, we found that the percentage
of HPV increases from CIN I to CIN III. Notwith-
standing the percentage per stage and that total
percentage is extremely high, in agreement with
the reports in the scientiﬁc literature related to
developing countries, we believe that the percent-
age of detection could be increased by improving
the technological tools, principally focussed on DNA
detection of HPV [9]. We also suggest efforts to
determine the principal HPV serotypes in each com-
munity to evaluate the potential beneﬁt of HPV
vaccine [10].
Despite the strong association between HPV and
cervical cancer, being a risk factor for relapse,
it is clear that the presence of other factors are
required for it to turn conversion into malignant.
In our city, where the people attending consulta-
tion at the IMSS are predominantly of low or very
low income groups, there are several concomitant
infections that could play an important role in the
evolution of this neoplasm.
During the one semester review, the median
age of 43 was higher than that reported in other
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tudies, but third and fourth decades of life are
till the predominant ranges for the appearance
f this disease. Meta-analysis of the literature has
evealed that disparities in cervical cancer screen-
ng rates become more pronounced with advancing
ge [11]. Decreased screening and treatment of
recancerous lesions likely contribute to the higher
ncidence of cervical cancer among older minority
opulations, and can also explain the observed later
tages of diagnosis. Adherence to follow-up after
n abnormal Pap smear is also low among minority
roups.
The general gyneco-obstetric antecedents show
he principal risk factor for developing this malig-
ancy in the studied population is multiparity, that
n most cases was associated to an early ﬁrst sexual
ntercourse which is also a signiﬁcant risk factor for
ervical cancer. The role of abortions and cervical-
terine cancer is not well deﬁned.
The high quality in 86.5% of cases gives con-
dence to the results. The tissues extracted by
urgical procedures were higher than those of biop-
ies because the General Regional Hospital is a
econd level health institution. The percentage of
otal pathological studies with at least one grade of
ervical-uterine cancer (18.18%) was very high tak-
ng into account that in developed countries this is
rare disease, unlike in developing countries where
his disease is relatively common, as has been pub-
ished by Lizano et al. [12] who found in 101 women
ith pathological cytologies, there were 54 cases
53.5%) of low-grade SIL and 47 cases (46.5%) of
igh-grade SIL out of a total of 277 women studied.
The high prevalence and incidence of CIN,
icro-invasive carcinoma and invasive carcinoma
n Mexico indicates that there is a wide sector of
he population escaping early detection. If mortal-
ty rates does not change in Mexico, 10,839 deaths
re predicted in the year 2050. In contrary to 3739
ases of in Europe (Fig. 1).
Since most cases are CIN III and CIS, there is an
ption for treatment with good prognosis of these
alignancy. Although some CIN I—III lesions would
eal spontaneously, management is based on surgi-
al excision of part of the uterine cervix because
uch lesions can potentially progress into carcino-
as. Most often this treatment leads to the cure of
ntra-epithelial lesions but the incidence of recur-
ence is 4.88/10,000 woman-months (HIV-negative)
13].
It is critical to take into account the vascular and
landular invasion (percentage near 20%) to decide
he pertinent therapeutical decision. To evaluate
he prognosis, besides invasion, it is important to
onsider the ﬁndings of metaplasia, keratinization,
ifferentiation grade and other lesions.
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[uman papillomavirus infection with cervical intrae
Within the limitations of observational, retro-
pective non-randomized study, our results are in
greement with those obtained from published ran-
omized trials which state the high prevalence
f HPV and cervical cancer [14]. Although the
eneral Regional Hospital 220, IMSS, is a sec-
nd level referal center and a reference center
hat could bias the real prevalence of HPV infec-
ion and cervical-uterine cancer, it is important
o say that the rural areas have lower coverage
f early cancer detection. It thus seems necessary
or public health policy makers and researchers to
horoughly understand the process failures in con-
emporary screening environments in order to plan
he implementation of future prevention modalities
15].
We conclude that HPV infection and cervical-
terine cancer have a very high prevalence in the
tate of Mexico, as reported in other develop-
ng countries [16]. Screening for cervical cancer
ased on testing for HPV increases the sensi-
ivity of detection of high-grade CIN (II or III).
oncomitant infections with HPV must be stud-
ed to identify the physiopathological involvement
f each one alone or in conjuntion and prog-
osis must be individualized taking into account
ll pathological data reported to evaluate the
rue dimension of our goals. As cervical can-
er continues to cause signiﬁcant morbidity and
ortality worldwide, prophylactic cervical cancer
accines seems to be a good option for its preven-
ion.
Finally, we support the idea previously published
o develop a generalized cost-effective analysis of
ap smear screening, high-risk HPV testing and the
PV vaccine, in the Mexican context. The success
f detection programs for any disease resides in its
mplementation and for cervical cancer diagnosis
his is not an exception. However, while there is
till no improvement in the population’s quality of
ife and education, advances in health programs will
till be poor.
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